Skip to content
Merged
Show file tree
Hide file tree
Changes from all commits
Commits
File filter

Filter by extension

Filter by extension

Conversations
Failed to load comments.
Loading
Jump to
Jump to file
Failed to load files.
Loading
Diff view
Diff view
4 changes: 2 additions & 2 deletions DESCRIPTION
Original file line number Diff line number Diff line change
@@ -1,8 +1,8 @@
Package: DoseFinding
Type: Package
Title: Planning and Analyzing Dose Finding Experiments
Version: 1.4-1.9000
Date: 2025-07-08
Version: 1.4-2.9000
Date: 2026-10-14
Authors@R: c(
person("Bjoern", "Bornkamp", email = "bjoern.bornkamp@novartis.com",
comment = c(ORCID = "0000-0002-6294-8185"), role = c("aut")),
Expand Down
7 changes: 7 additions & 0 deletions NEWS.md
Original file line number Diff line number Diff line change
@@ -1,5 +1,12 @@
# DoseFinding (development version)

# DoseFinding 1.4-2
* Added vignette illustrating analysis of time-to-event data (#9. thanks to Carina Miller for her work on this)
* added contributors section to readme (#40)
* plot.DRMod now also works correctly when arguments are provided as expressions (#51)
* updated link for github installation (#44)
* Rdpack is now used to handle references (#43)

# DoseFinding 1.4-1
* Added powMCTInterim function to implement conditional/predictive power
calculations for interim analyses (#10)
Expand Down
2 changes: 1 addition & 1 deletion README.Rmd
Original file line number Diff line number Diff line change
Expand Up @@ -100,7 +100,7 @@ as listed in the `DESCRIPTION` file.

### Other authors and substantial contributors

- Ludger Sandig — Vignettes
- Ludger Sandig — Vignettes, testthat framework
- Marius Thomas — Bayesian MCP-mod, various updates to code, docs, and tests
- Daniel Sabanes Bove — powMCTInterim implementation, longitudinal data vignette
- Carina Miller - Time-to-event vignette
Expand Down
2 changes: 1 addition & 1 deletion README.md
Original file line number Diff line number Diff line change
Expand Up @@ -132,7 +132,7 @@ package authors and maintainers as listed in the `DESCRIPTION` file.

### Other authors and substantial contributors

- Ludger Sandig — Vignettes
- Ludger Sandig — Vignettes, testthat framework
- Marius Thomas — Bayesian MCP-mod, various updates to code, docs, and
tests
- Daniel Sabanes Bove — powMCTInterim implementation, longitudinal data
Expand Down
7 changes: 3 additions & 4 deletions cran-comments.md
Original file line number Diff line number Diff line change
@@ -1,8 +1,7 @@
## Resubmission
This is a resubmission. In this version I have made the following updates to reduce check time

* added skips for long running tests
* skipped evaluation for long-running vignette code
This is a resubmission. In this version I have made the following updates
* fixed broken links
* made changes to one vignette to speed up checks

## R CMD check results

Expand Down
2 changes: 1 addition & 1 deletion inst/REFERENCES.bib
Original file line number Diff line number Diff line change
Expand Up @@ -31,7 +31,7 @@ @article{biesheuvel2002
number={1},
pages={101--116},
year={2002},
doi = {10.1002/1521-4036(200201)44:13.0.CO;2-H},
doi = {10.1002/1521-4036(200201)44:1<101::AID-BIMJ101>3.0.CO;2-H},
publisher={Wiley Online Library}
}

Expand Down
2 changes: 1 addition & 1 deletion tests/testsMCT.R
Original file line number Diff line number Diff line change
Expand Up @@ -260,7 +260,7 @@ exm2<-c(0.05,5)
expo<-0.2
quad<--0.6
beta<-c(0.05,4)
data.sim <- structure(list(X = structure(1:4, .Label = c("0", "10", "20", "40"), class = "factor"),
data.sim <- structure(list(X = structure(1:4, levels = c("0", "10", "20", "40"), class = "factor"),
dose = c(0L, 10L, 20L, 40L),
Estimate = c(0.266942236, 3.792703657, 14.69084734, 17.71179102),
Cov1 = c(3.685607913, 0.595285049, 0.651289991, 0.742901538),
Expand Down
2 changes: 1 addition & 1 deletion vignettes/analysis_normal.Rmd
Original file line number Diff line number Diff line change
Expand Up @@ -21,7 +21,7 @@ There is a separate vignette with details on [sample size and power calculation]
We will use data from @verkindre2010,
who actually use a cross-over design and utilize MCP-Mod in a supportive analysis.
More information can be found at the corresponding
[clinicaltrials.gov page](https://www.clinicaltrials.gov/study/NCT00501852)
[clinicaltrials.gov page](https://clinicaltrials.gov/study/NCT00501852)
and on the R help page `?glycobrom`.

The main purpose @verkindre2010 was to provide safety and efficacy data on Glycopyrronium Bromide (NVA237)
Expand Down
2 changes: 1 addition & 1 deletion vignettes/time_to_event_data.Rmd
Original file line number Diff line number Diff line change
Expand Up @@ -672,7 +672,7 @@ sampSizeMCT_TTE <- function(mods,
Now we can calculate how many patients we would need to recruit to achieve an average power of 80%, assuming we would
recruit for 2 years and we would end the study after 4 years.
```{r}
sampSizeMCT_TTE(mods, alpha = 0.025, alRatio = alRatio, end_rec = 2, end_stu = 4, targPow = 0.8, lowerN = 100, upperN = 500)
sampSizeMCT_TTE(mods, alpha = 0.025, alRatio = alRatio, end_rec = 2, end_stu = 4, targPow = 0.8, lowerN = 100, upperN = 300)
```


Expand Down
Loading